VICTORIA has recorded no new COVID-19 cases, with more than 16,000 test results received.
It marks the 47th day without new locally acquired cases. There were also no new infections acquired interstate or internationally.
There remain three known active cases of the virus in Victoria.
Victoria's vaccination tally sits at 152,363, with 2890 doses administered in the 24-hours to midnight.
COVID-19 viral fragments have been detected in wastewater from the Ringwood area in Melbourne.
The health department has urged anyone in the following suburbs from April 6 - 9 to get tested for even the mildest of COVID-19 symptoms: Bayswater, Bayswater North, Boronia, Croydon, Croydon North, Croydon South, Heathmont, Kilsyth, Kilsyth South, Montrose, Ringwood, Ringwood East, Sassafras, The Basin, Tremont and Wantirna.
Australia on Monday recorded its 910th coronavirus fatality, after an 80-year-old man died in Brisbane.
The man tested positive for COVID-19 on his fifth day in hotel quarantine, having returned from the Philippines.
He was taken to the Prince Charles Hospital on March 25, but never recovered. It is Australia's first COVID-19 death for the year.
All except for five of Australia's deaths to COVID-19 are in people aged 50 and over, Therapeutic Goods Administration head John Skerritt said.
"That's why vaccination in that group is so important," Professor Skerritt said.
Prime Minister Scott Morrison has requested the national cabinet meet more frequently in response to the challenges associated with the vaccination program.
He is today expected to address business leaders in Perth about the government's health and economic response to the COVID-19 pandemic.
A second case of rare blood clots has been identified in a woman in her 40s, who got the AstraZeneca vaccine in Western Australia.
The woman is in a stable condition in hospital, the AAP reports.
With the AstraZeneca vaccine no longer recommended for Australians under the age of 50, the federal government is looking to add the Novavax vaccine to its program.
Australia has ordered 51 million doses of the vaccine, with hopes to add them to the vaccine arsenal in June.
While Professor Skerritt said early results were positive, clinical trials of the Novavax vaccine had not yet been completed, and the manufacturer needed to establish large-scale manufacturing arrangements.
Health experts have suggested the federal government utilise its primary health network to expand its vaccine program delivery.
The health department reportedly identified vaccine supply as the largest challenge in the early stages of the rollout, and said primary health networks were not responsible for delivering clinical services.
- with AAP
The Mail-Times has removed the paywall from our stories relating to health warnings and safety of the community in regards to the coronavirus. However, we depend on subscription revenue to support our journalism. If you are able, please subscribe here. If you are already a subscriber, thank you for your support.
Our journalists work hard to provide local, up-to-date news to the community. This is how you can continue to access our trusted content: